Animal models for the human gastrointestinal tract

Gastrointestinal Microbiology

Volumn , Issue , 2006, Pages 253-272

  Henriksson, Anders ^a  

^a DSM FOOD SPECIALTIES   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78149467347     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (131)

1. Luick BR, Penner MH. Nominal response of passage rates to fiber particle size in rats. J Nutr 1991; 121:1940-1947.
2. Sakaguchi E, Itoh H, Uchida S, Horigome T. Comparison of fibre digestion and digesta retention time between rabbits, guinea-pigs, rats and hamsters. Br J Nutr 1987; 58:149-158.
3. Stevens CE. Comparative Physiology of the Vertebrate Digestive System. New York: Cambridge University Press, 1988.
4. Savage DS. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1977; 31:107-133.
5. Smith WH. Observations on the flora of the alimentary tract of animals and factors affecting its composition. J Pathol Bacteriol 1965; 89:95-122.
6. Tannock GW. Normal microbiota of the gastrointestinal tract of rodents. In: Mackie RI, White BA, Isaacson RE, eds. Gastrointestinal Microbiology. New York: Chapman & Hall, 1997 pp. 187-215.
7. Holdeman LV, Good IJ, Moore WEC. Human fecal flora: variation in bacterial composition within individuals and a possible effect on emotional stress. Appl Environ Microbiol 1976; 31:359-375.
8. Moore WEC, Holdeman LV. Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Microbiol 1974; 27:961-979.
9. Drasar BS, Barrow PA. Intestinal Microbiology. Washington: Van Nostrand Reinhold, 1985.
10. Finegold SM, Attebery HR, Sutter VL. Effect of diet on human fecal flora: comparison of Japanese and American diets. Am J Clin Nutr 1974; 27:1456-1469.
11. Mitsuoka T. Taxonomy and ecology of the indigenous intestinal bacteria. Recent Advances in Microbial Ecology. Tokyo: Japan Scientific Societies Press, 1989 pp. 493-498.
12. Rickard KL, Folino M, McIntyre A, Albert V, Muir J, Young GP. Colonic epithelial biology; comparison of resistant starch to soluble and insoluble dietary fibres. Processing Nutr Soc 1994; 18:57.
13. Barnes RH, Fiala G, McGehee B, Brown A. Prevention of coprophagy in the rat. J Nutr 1957; 63:489-528.
14. Barnes RH. Nutritional implications of coprophagy. Nutr Rev 1962; 20:289-291.
15. Fitzgerald RJ, Gustafsson BE, McDaniel EG. Effects of coprophagy prevention on intestinal microflora in rats. J Nutr 1964; 84:155-160.
16. Smith HW, Jones JET. Observations on the alimentary tract and its bacterial flora in healthy and diseased pigs. J Pathol Bacteriol 1963; 86:387-412.
17. Cross ML. Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. FEMS Immunol Med Microbiol 2002; 34:245-253.
18. Schiffrin EJ, Blum S. Interactions between the microbiota and the intestinal mucosa. Eur J Clin Nutr 2002; 56:S60-S64.
19. Borchers AT, Keen CL, Gershwin ME. The influence of yogurt/Lactobacillus on the innate and acquired immune response. Clin Rev Allergy Immunol 2002; 22:207-230.
20. Berg RD, Owens WE. Inhibition of translocation of viable Escherichia coli from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 1979; 25:820-827.
21. Berg RD. Inhibition of Escherichia coli translocation from the gastrointestinal tract by normal cecal flora in gnotobiotic or antibiotic-decontaminatedmice. Infect Immun 1980; 29:1073-1081.
22. Berg RD. Promotion of the translocation of enteric bacteria from the gastrointestinal tracts of mice by oral treatment with penicillin, clindamycin, or metronidazole. Infect Immun 1981; 33:854-861.
23. Perdigon G, Maldonado Galdeano C, Valdez JC, Medici M. Interaction of lactic acid bacteria with the gut immune system. Eur J Clin Nutr 2002; 56:S21-S26.
24. Sudo N, Yu XN, Aiba Y, et al. An oral introduction of intestinal bacteria prevents the development of a long-term Th2-skewed immunological memory induced by neonatal antibiotic treatment in mice. Clin Exp Allergy 2002; 32:1112-1116.
25. Perdigon G, Nader ME, Alvarez MS, Oliver G, Holgado AAPD. Effect of perorally administered lactobacilli on macrophage activation in mice. Infect Immun 1986; 53:404-410.
26. Takagi A, Matsuzaki T, Sato M, Nomoto K, Morotomi M, Yokokura T. Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism. Carcinogenesis 2001; 22:599-605.
27. Gill HS, Rutherfurd KJ, Cross ML. Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J Clin Immunol 2001; 21:264-271.
28. Oozeer R, Goupil-Feuillerat N, Alpert CA, et al. Lactobacillus casei is able to survive and initiate protein synthesis during its transit in the digestive tract of human flora-associated mice. Appl Environ Microbiol 2002; 68:3570-3574.
29. Kato I, Endo-Tanaka K, Yokokura T. Suppressive effects of the oral administration of Lactobacillus casei on the type II collagen-induced arthritis in DBA/1 mice. Life Sci 1998; 63:635-644.
30. Gill HS, Rutherfurd KJ. Viability and dose-response studies on the effects of the immunoenhancing lactic acid bacterium Lactobacillus rhamnosus in mice. Br J Nutr 2001; 86:285-289.
31. Gill HS, Shu Q, Lin H, Rutherfurd KJ, Cross ML. Protection against translocating Salmonella typhimurium infection in mice by feeding the immuno-enhancing probiotic Lactobacillus rhamnosus strain HN001. Med Microbiol Immunol 2001; 190:97-104.
32. Henriksson A, Conway PL. Colonization resistance induced in mice orogastrically dosed with human fecal homogenates from different donors. Microbiol Ecol Health Dis 2001; 13:96-99.
33. Henriksson A, Conway PL. Isolation of the human fecal bifidobacteria which reduce signs of Salmonella infection when orogastrically dosed to mice. J Appl Microbiol 2001; 90:223-228.
34. Cross ML, Mortensen RR, Kudsk J, Gill HS. Dietary intake of Lactobacillus rhamnosus HNOO1 enhances production of both Th1 and Th2 cytokines in antigen-primed mice. Med Microbiol Immunol 2002; 191:49-53.
35. Mahoney M, Henriksson A. The effect of processed meat and meat starter cultures on gastrointestinal colonization and virulence of Listeria monocytogenes in mice. Int J Food Microbiol 2003; 84:255-261.
36. Pestka JJ, Ha C-L, Warner RW, Lee JH, Ustunol Z. Effects of ingestion of yoghurts containing Bifidobacterium and Lactobacillus on spleen and peyer’s patch lymphocyte populations in the mouse. J Food Prot 2001; 64:392-395.
37. Hirayama K, Baranczewski P, Akerlund JE, Midtvedt T, Moller L, Rafter J. Effects of human intestinal flora on mutagenicity of and DNA adduct formation from food and environmental mutagens. Carcinogenesis 2000; 21:2105-2111.
38. Waidmann M, Bechtold O, Frick JS, et al. Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice. Gastroenterology 2003; 125:162-177.
39. Balish E, Warner T. Enterococcus fecalis induces inflammatory bowel disease in interleukin- 10 knockout mice. Am J Pathol 2002; 160:2253-2257.
40. Schultz M, Veltkamp C, Dieleman LA, et al. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm Bowel Dis 2002; 8:71-80.
41. McCarthy J, O’Mahony L, O’Callaghan L, et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003; 52:975-980.
42. Steidler L, Hans W, Schotte L, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10, [comment]. Science 2000; 289:1352-1355.
43. Hudault S, Lievin V, Bernet-Camard MF, Servin AL. Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol 1997; 63:513-518.
44. Silva SH, Vieira EC, Dias RS, Nicoli JR. Antagonism against Vibrio cholera by diffusible substances produced by bacterial components of the human fecal microbiota. J Med Microbiol 2001; 50:161-164.
45. Li Z, Yang S, Lin H, et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease, [comment]. Hepatology 2003; 37:343-350.
46. Konrad A, Mahler M, Flogerzi B, et al. Amelioration of murine colitis by feeding a solution of lysed Escherichia coli. Scand J Gastroenterol 2003; 38:172-179.
47. Rouzaud G, Rabot S, Ratcliffe B, Duncan AJ. Influence of plant and bacterial myrosinase activity on the metabolic fate of glucosinolates in gnotobiotic rats. Br J Nutr 2003; 90:395-404.
48. Roland N, Nugon-Bandon L, Flinois P, Beaune P. Hepatic and intestinal cytochrome P-450, glutathione-transferase and UDP-glucuronosyl transferase are affected by six types of dietary fiber in rats inoculated with human whole fecal flora. J Nutr 1994; 124:1581-1587.
49. Tache S, Peiffer G, Millet AS, Corpet DE. Carrageenan gel and aberrant crypt foci in the colon of conventional and human flora-associated rats. Nutr Cancer 2000; 37:193-198.
50. Sidhu H, Allison MJ, Chow JM, Clark A, Peck AB. Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes. J Urol 2001; 166:1487-1491.
51. Adawi D, Ahrne S, Molin G. Effects of different probiotic strains of Lactobacillus and Bifidobacterium on bacterial translocation and liver injury in an acute liver injury model. Int J Food Microbiol 2001; 70:213-220.
52. McIntosh GH, Royle PJ, Playne MJ. A probiotic strain of L. acidophilus reduces DMHinduced large intestinal tumors in male Sprague-Dawley rats. Nutr Cancer 1999; 35:153-159.
53. Kennedy RJ, Hoper M, Deodhar K, Kirk SJ, Gardiner KR. Probiotic therapy fails to improve gut permeability in a hapten model of colitis. Scand J Gastroenterol 2000; 35:1266-1271.
54. Eizaguirre I, Urkia NG, Asensio AB, et al. Probiotic supplementation reduces the risk of bacterial translocation in experimental short bowel syndrome. J Pediatr Surg 2002; 37:699-702.
55. Wang X, Brown IL, Evans AJ, Conway PL. The protective effects of high amylose maize (amylomaize) starch granules on the survival of Bifidobacterium spp. in the mouse gastrointestinal tract. J Appl Microbiol 1999; 87:631-639.
56. Hudault S, Lievin V, Bernet-Camard MF, Servin AL. Antagonistic activity exerted in vivo and in vitro by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol 1997; 63:513-518.
57. Cohen PS, Rossoll R, Cabelli VJ, Yang S-L, Laux DC. Relationship between the mouse colonizing ability of a human fecal Esherichia coli strain and its ability to bind a specific mouse colonic mucous gel protein. Infect Immun 1983; 40:62-69.
58. Paubert-Braquet M, Xiao-Hu G, Gaudichon C, et al. Enhancement of host resistance against Salmonella typhimurium in mice fed a diet supplemented with yogurt or milks fermented with warious Lactobacillus casei strains. Int J Immunother 1995; XI:153-161.
59. Shu Q, Lin H, Rutherfurd KJ, et al. Dietary Bifidobacterium lactis (HN019) ennhances resistance to oral Salmonella typhimurium infection in mice. Microbiol Immunol 2000; 44:213-222.
60. Bovee-Oudenhoven IM. Increasing the intestinal resistance of rats to the invasive pathogen Salmonella enteritidis: additive effects of dietary lactulose and calcium. Gut 1997; 40:497-504.
61. Shu Q, Gill HS. Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice. FEMS Immunol Med Microbiol 2002; 34:59-64.
62. Shu Q, Gill HS. A dietary probiotic (Bifidobacterium lactis HN019) reduces the severity of Escherichia coli O157:H7 infection in mice. Med Microbiol Immunol 2001; 189:147-152.
63. DeWaard R, Garssen J, Bokken GCAM, Vos JG. Antagonistic activity of Lactobacillus casei strain Shirota against gastrointestinal Listaria monocytogenes infection in rats. Int J Food Microbiol 2002; 73:93-100.
64. Mahoney M, Henriksson A. The effect of processed meat and meat starter cultures on gastrointestinal colonization and virulence of Listeria monocytogenes in mice. Int J Food Microbiol 2001; 84:255-261.
65. Bernet-Camard MF, Lievin V, Bassart D, Neeser JR, Servin AL, Hudault S. The human Lactobacillus acidophilus strain LA1 secrets a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl Environ Microbiol 1997; 63:2747-2753.
66. Voravuthikunchai SP. Investigation of Caecectomy as a Perturbation of the Mouse Intestinal Ecosystem. Sydney: The University of New South Wales, 1988.
67. Babour AH, Rampling A, Hormaeche CE. Variation in the infectivity of Listeria monocytogenes isolates following intregastric inoculation of mice. Infect Immun 2001.
68. Yuki N, Watanabe K, Mike A, et al. Survival of a probiotic, Lactobacillus casei strain Shirota, in the gastrointestinal tract: selective isolation from feces and identification using monoclonal antibodies. Int J Food Microbiol 1999; 48:51-57.
69. Saxelin M, Elo S, Salminen S, Vapaatalo H. Dose response colonization of feces after oral administration of Lactobacillus casei strain GG. Microb Ecol Health Dis 1991; 4:209-214.
70. Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L, Salminen S. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci 1992; 37:121-128.
71. Charteris WP, Kelly PM, Morelli L, Collins JK. Selective detection, enumeration and identification of potentialy probiotic Lactobacillus and Bifidobacterium species in mixed bacterial populations. Int J Food Microbiol 1997; 35:1-27.
72. Lynch PA, Gilpin BJ, Sinton LW, Savill MG. The detection of Bifidobacterium adolescentis by colony hybridization as an indicator of human fecal pollution. J Appl Microbiol 2002; 92:526-533.
73. Lucchini F, Kmet V, Cesena C, Coppi L, Bottazzi V, Morelli L. Specific detection of a probiotic Lactobacillus strain in fecal samples by using multiplex PCR. FEMS Microbiol Lett 1998; 158:273-278.
74. Kaneko T, Kurihara H. Digoxigenin-labeled deoxyribonucleic acid probes for the enumeration of bifidobacteria in fecal samples. J Dairy Sci 1997; 80:1254-1259.
75. Su P, Tandianus JE, Park JH, Henriksson A, Dunn NW. A colony hybridization method for Bifidobacterium lactis LAFTI B94. Aust Dairy Technol 2003; 58:213.
76. Tannock GW, Crichton C, Welling GW, Koopman JP, Midtvedt T. Reconstitution of the gastrointestinal microflora of lactobacillus-free mice. Appl Environ Microbiol 1988; 54:2971-2975.
77. Tannock GW, Dashkevicz MP, Feighner SD. Lactobacilli and bile salt hydrolase in the murine intestinal tract. Appl Environ Microbiol 1989; 55:1848-1851.
78. McConell MA, Tannock GW. Lactobacilli do not influence enzyme activities of duodenal enterocytes of mice. Microb Ecol Health Dis 1993; 6:315-318.
79. Midtvedt T, Gustafsson BE. Microbial convesion of bilirubin to urobilin in vitro and in vivo. Acta Pathol Microbiol Scand Sect B 1981; 89:57-60.
80. Norin KE, Midtvedt T, Gustafsson BE. Influence of intestinal microflora on the tryptic activity during lactation in rats. Lab Anim Sci 1986; 20:234-237.
81. Corthier C, Dubos F, Ducluzeau R. Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii. Can J Microbiol 1986; 32:894-896.
82. Rodrigues ACP, Nardi RM, Bambirra EA, Vieira EC, Nicoli JR. Effects of Saccharomyces boulardii against oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice. J Appl Bacteriol 1996; 81:251-256.
83. Wilson KH, Sheagren JN, Freter R, Weatherbee L, Lyerly D. Gnotobiotic models for study of the microbial ecology of Clostridium difficile and Escherchia coli. J Infect Dis 1986; 153:547-551.
84. Kabir AM, Aiba Y, Takagi A, Kamiya S, Miwa T, Koga Y. Prevention of helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 1997; 41:49-55.
85. Kleessen B, Hartmann L, Blaut M. Oligofructose and long-chain inulin: influence on the gut microbial ecology of rats associated with a human fecal flora. Br J Nutr 2001; 86:291-300.
86. Chikai T, Nakao H, Uchida K. Deconjugation of bile acids by human intestinal bacteria implanted in germ-free rats. Lipids 1987; 22:669-671.
87. Herías MV, Hessle C, Telemo E, Midtvedt T, Hanson LÅ, Wold AE. Immunomodulatory effects of Lactobacillus plantarum colonizing the intestine of gnotobiotic rats. Clin Exp Immunol 1999; 116:283-290.
88. Scharek L, Hartmann L, Heinevetter L, Blaut M. Bifidobacterium adolescentis modulates the specific immune response to another human gut bacterium, Bacteroides thetaiotaomicron, in gnotobiotic rats. Immunobiology 2000; 202:429-441.
89. Hooper LV, Midtvedt T, Gordon JI. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 2002; 22:283-307.
90. Husebye E, Hellstrom PM, Sundler F, Chen J, Midtvedt T. Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol 2001; 280:G368-G380.
91. Kleessen B, Hartmann L, Blaut M. Fructans in the diet cause alterations of intestinal mucosal architecture, released mucins and mucosa-associated bifidobacteria in gnotobiotic rats. Br J Nutr 2003; 89:597-606.
92. Lin JH-C, Savage DC. Host specificity of the colonization of murine gastric epithelium by lactobacilli. FEMS Microbiol Lett 1984; 24:67-71.
93. Conway PL, Henriksson A. Strategies for the isolation and characterization of functional probiotics. Human Health: The Contribution of Microorganisms. London: Springer-Verlag, 1993 pp. 75-94.
94. Mallett AK, Bearne CA, Rowland IR, Farthing MJ, Cole CB, Fuller R. The use of rats associated with a human fecal flora as a model for studying the effects of diet on the human gut microflora. J Appl Bacteriol 1987; 63:39-45.
95. Hirayama K. Ex-germfree mice harboring intestinal microbiota derived from other animal species as an experimental model for ecology and metabolism of intestinal bacteria. Exp Anim 1999; 48:219-227.
96. Hirayama K, Miyaji K, Kawamura S, Itoh K, Takahashi E, Mitsuoka T. Development of intestinal flora of human-flora-associated (HFA) mice in the intestine of their offspring. Exp Anim 1995; 44:219-222.
97. Silvi S, Rumney CJ, Cresci A, Rowland IR. Resistant starch modifies gut microflora and microbial metabolism in human flora-associated rats inoculated with feces from Italian and U.K. donors. J Appl Microbiol 1999; 86:521-530.
98. Bowey E, Adlercreutz H, Rowland I. Metabolismof isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats. Food Chem Toxicol 2003; 41:631-636.
99. Ward FW, Coates ME, Cole CB, Fuller R. Effect of dietary fats on endogenous formation of N-nitrosamines from nitrate in germ-free and conventional rats and rats harbouring a human flora. Food Addit Contam 1990; 7:597-604.
100. Kamlage B, Hartmann L, Gruhl B, Blaut M. Linoleic acid conjugation by human intestinal microorganisms is inhibited by glucose and other substrates in vitro and in gnotobiotic rats. J Nutr 2000; 130:2036-2039.
101. Roland N, Nugon-Baudon L, Andrieux C, Szylit O. Comparative study of the fermentative characteristics of inulin and different types of fibre in rats inoculated with a human whole fecal flora. Br J Nutr 1995; 74:239-249.
102. Djouzi Z, Andrieux C. Compared effects of three oligosaccharides on metabolism of intestinal microflora in rats inoculated with a human fecal flora. Br J Nutr 1997; 78:313-324.
103. Lhoste EF, Ouriet V, Bruel S, et al. The human colonic microflora influences the alterations of xenobiotic-metabolizing enzymes by catechins in male F344 rats. Food Chem Toxicol 2003; 41:695-702.
104. Barrow PA, Brooker BE, Fuller BE, Newport MJ. The attachment of bacteria to the gastric epithelium of the pig and its importance in the microbiology of the intestine. J Appl Bacteriol 1980; 48:147-154.
105. Jonsson E, Conway PL. Probiotics for pigs. In: Fuller R, ed. Probiotics, the Scientific Basis. London: Chapman & Hall, 1992:87-110.
106. Voravuthikunchai SP, Lee A. Cecectomy causes long-term reduction of colonization resistance in the mouse gastrointestinal tract. Infect Immun 1987; 55:995-999.
107. Henriksson A, Khaled AKD, Conway PL. The effect of caecectomy on the fecal concentrations of urobilinogen and active trypsin in mice. Microb Ecol Health Dis 1996; 9:61-65.
108. Simmons HA, Ford EJ. Multiple cannulation of the large intestine of the horse. Br Vet J 1988; 144:449-454.
109. Walker JA, Harmon DL, Gross KL, Collings GF. Evaluation of nutrient utilization in the canine using the ileal cannulation technique. J Nutr 1994;2672S-2676S.
110. Hagberg L, Bruce AW, Reid G, Edén CS, Lincoln K, Lidin-Janson G. Colonization of the urinary tract with bacteria from the normal fecal and urethral flora in patients with recurrent urinary tract infections. In: Kass HE, Edén CS, eds. Host-Parasite Interactions in Urinary Tract Infections. Chicago: University of Chicago Press, 1989:194-197.
111. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene, [comment]. Cell 1993; 75:253-261.
112. Kuˆhn RJ, Lohler J, Rennick D, Rajewsky K, Muˆ ller W. Interleukin 10-deficient micedevelop chronic enterocolitis. Cell 1993; 75:263-274.
113. Gaskins HR, Vondrak-Juergens GL, McCracken BA, Woolsey JH. Specific-pathogen-free conditions enhance inflammatory bowel disease in T-cell receptor knockout, but not C3H/HeJBir mice, [comment]. Lab Anim Sci 1997; 47:650-655.
114. Dianda L, Hanby AM, Wright NA, Sebesteny A, Hayday AC, Owen MJ. T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol 1997; 150:91-97.
115. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice, [comment]. Cell 1993; 75:274-282.
116. Taurog JD, Richardson JA, Croft JT, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994; 180:2359-2364.
117. Desreumaux P, Colombel JF. Intestinal flora and Crohn’s disease. Ann Pharm Fr 2003; 61:276-281.
118. McCarthy J, O’Mahony L, O’Callaghan L, et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003; 52:957-980.
119. Steidler L. In situ delivery of cytokines by genetically engineered Lactococcus lactis. Antonie van Leeuwenhoek 2002; 82:323-331.
120. Hambly RJ, Rumney CJ, Fletcher JM, Rijken PJ, Rowland IR. Effects of high- and low-risk diets on gut microflora-associated biomarkers of colon cancer in human flora-associated rats. Nutr Cancer 1997; 27:250-255.
121. Yamazaki K, Tsunoda A, Sibusawa M, et al. The effect of an oral administration of Lactobacillus casei strain shirota on azoxymethane-induced colonic aberrant crypt foci and colon cancer in the rat. Oncol Rep 2000; 7:977-982.
122. Rumney CJ, Rowland IR, Coutts TM, et al. Effects of risk-associated human dietary macrocomponents on processes related to carcinogenesis in human-flora-associated (HFA) rats. Carcinogenesis 1993; 14:79-84.
123. Knasmuller S, Steinkellner H, Hirschl AM, Rabot S, Nobis EC, Kassie F. Impact of bacteria in dairy products and of the intestinal microflora on the genotoxic and carcinogenic effects of heterocyclic aromatic amines. Mutat Res 2001; 480-481:129-138.
124. Horie H, Zeisig M, Hirayama K, Midtvedt T, Moller L, Rafter J. Probiotic mixture decreases DNA adduct formation in colonic epithelium induced by the food mutagen 2-amino-9Hpyrido[2,3-b]indole in a human-flora associated mouse model. Eur J Cancer Prev 2003; 12:101-107.
125. Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a doubleblind trial. The BLP Study Group. Eur Urol 1995; 27:104-109.
126. Aso Y, Akazan H. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP Study Group. Urol Int 1992; 49:125-129.
127. Hughes R, Rowland IR. Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon. Carcinogenesis 2001; 22:43-47.
128. Glick ME, Falchuk ZM. Dinitrochlorobenzene-induced colitis in the guinea-pig: studies of colonic lamina propria lymphocytes. Gut 1981; 22:120-125.
129. Rachmilewitz D, Simon PL, Schwartz LW, Griswold DE, Fondacaro JD, Wasserman MA. Inflammatory mediators of experimental colitis in rats. Gastroenterology 1989; 97:326-337.
130. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Buschenfelde KH. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) [comment]. Clin Exp Immunol 1995; 102:448-455.
131. Shibolet O, Karmeli F, Eliakim R, et al. Variable response to probiotics in two models of experimental colitis in rats. Inflamm Bowel Dis 2002; 8:399-406.